FB Nasdaq FB Facebook

Losers at NYSE: Aeropostale Inc. (NYSE:ARO), Santander Mexico Fincl Gp SAB (NYSE:BSMX), Empresas ICA (NYSE:ICA), XO Group (NYSE:XOXO)

Aeropostale Inc. (NYSE:ARO) reported a fourth quarter adjusted loss of $0.35 per share after the close Thursday, compared to the consensus estimate of a loss of $0.31 per share. Aeropostale Inc. (NYSE:ARO) stock performance was -20.14% in last session and finished the day at $5.83. Traded volume was 37.47 million shares in the last session…

Read More
FB Nasdaq FB Facebook

Gainers At NYSE: Companhia Siderurgica Nacional (NYSE:SID), GameStop Corp. (NYSE:GME), Generac Holdings (NYSE:GNRC), Spirit Realty Capital (New) (NYSE:SRC)

Companhia Siderurgica Nacional (NYSE:SID) is a Brazil-based company primarily engaged in the steel industry. The Company divides its business into five segments: Steel sector, which is involved in the production, distribution and marketing of flat steel, galvanized steel and metal packaging. Companhia Siderurgica Nacional (ADR) (NYSE:SID) stock performance was 12.64% in last session and finished…

Read More

Biotech Unusual Volume: Tengion (OTCMKTS:TNGN), Alseres Pharmaceuticals (OTCMKTS:ALSE), Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN)

Tengion, Inc. (OTCMKTS:TNGN) on Mar. 3 issued notices to the holders (the “2012 Investors”) of senior secured notes issued on October 2, 2012 and to the holders (the “2013 Investors” and together with the 2012 Investors, the “Investors” and each, an “Investor”) of senior secured notes issued on June 28, 2013 stating that the Company…

Read More

Biotech active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Ariad Pharmaceuticals (NASDAQ:ARIA)

Bristol-Myers Squibb & Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that the FDA has approved an additional indication of Bristol’s anti-blood clot medicine, Eliquis. Pfizer Inc. (NYSE:PFE) stock performance was 0.35% in last session and finished the day at $31.23. Traded volume was 27.11 million shares in the last session and the average volume…

Read More

Biotech Stocks New Highs: Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN), Celladon Corp (NASDAQ:CLDN), Kindred Biosciences (NASDAQ:KIN)

Fate Therapeutics, Inc. (NASDAQ:FATE) announced that it has enrolled the first patient in its phase II study (PUMA − P rohema in UM bilical cord blood transplant in A dults) on Prohema. Fate Therapeutics Inc. (NASDAQ:FATE) stock performance was 27.14% in last session and finished the day at $11.15. Traded volume was 295,227.00 shares in…

Read More

Biotech Stocks Touching New Highs: Relypsa Inc. (NASDAQ:RLYP), Vanda Pharmaceuticals (NASDAQ:VNDA), OHR Pharmaceutical (NASDAQ:OHRP), Xencor (NASDAQ:XNCR)

Relypsa, Inc. (NASDAQ:RLYP) is a pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Relypsa Inc. (NASDAQ:RLYP) stock performance was 2.66% in last session and finished the day at $43.62. Traded volume was 126,739.00 shares in the last session and…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓